Company: SHPH
Filing Date: 2025-02-13
Form Type: S-1
Source: 0001493152-25-006202
Chunk: 165

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-13
Form: S-1
Chunk 165
---
3 and 2022                                               
 Consolidated                                                                                 
 Statements of Operations for the Years Ended December 31, 2023 and 2022                      | Page 
 F-21 
 F-22 
 F-23 |
|:---------------------------------------------------------------------------------------------|:-----|
| Consolidated                                                                                 
 Statements of Changes in Stockholders’ Equity for the Years Ended December 31, 2023 and 2022 | F-24 |
| Consolidated                                                                                 
 Statements of Cash Flows for the Years Ended December 31, 2023 and 2022                      | F-25 |
| Notes                                                                                        
 to Consolidated Financial Statements                                                         | F-26 |

| F-1 |

<div align='center'>Shuttle Pharmaceuticals Holdings, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)</div>

| Assets                                                                                   
 Current assets                                                                           |     | September 30, 
 2024          |             |   |     | December 31, 
 2023         |             |   |
|:-----------------------------------------------------------------------------------------|:----|:--------------|------------:|:--|:----|:-------------|------------:|:--|
| Cash and cash equivalents                                                                |     | $             |     156,656 |   |     | $            |   2,576,416 |   |
| Prepaid expenses                                                                         |     |               |     103,040 |   |     |              |     114,473 |   |
| Marketable securities                                                                    |     |               |           - |   |     |              |   2,887,215 |   |
| Accrued interest income                                                                  |     |               |           4 |   |     |              |      14,901 |   |
| Deferred costs                                                                           |     |               |     101,651 |   |     |              |           - |   |
| Total Current Assets                                                                     |     |               |     361,351 |   |     |              |   5,593,005 |   |
| Property and equipment, net                                                              |     |               |      21,160 |   |     |              |      24,827 |   |
| Other assets                                                                             |     |               |             |   |     |              |             |   |
| Operating lease right-of-use asset                                                       |     |               |     291,057 |   |     |              |     333,904 |   |
| Total Assets                                                                             |     | $             |     673,